- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00913679
A Comparison of Two Different Surgical Techniques in Hip Resurfacing Arthroplasty
A Comparison of Two Different Surgical Techniques to Preserve the Bony Supply and Improve Implant Longevity in Hip Resurfacing Arthroplasty
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
BACKGROUND:
6700 total hip replacements are performed each year in Denmark due to osteoarthritis. Young patients sustain a substantial risk of early implant failure due to high-activity daily living, and among patients younger than 55 years at surgery 20 percent need revision surgery within ten years. Revision surgery is more complicated than primary surgery and associated with decreased implant longevity due to decreased bone stock. Resurfacing hip arthroplasty (RHA), restores the anatomy of the hip as only the articulating joint surfaces are replaced, and thus more bone is left to ensure a better opportunity of successful revision surgery later on. The clinical midterm evaluation of RHA survival is promising, but two major complications leading to early revision, namely osteonecrosis and femoral neck fracture, has raised concern regarding the influence of surgical technique on the vascularity of the femoral head. RHA is commonly performed through a posterolateral surgical approach. By this technique muscle tendons are spilt resulting in decreased patient mobility for several weeks after surgery, but more importantly, the blood supply is compromised as a large artery has to be ligated. This is speculated to decrease the blood supply to femoral head and neck and thereby increase the risk of osteonecrosis, femoral neck fracture, and implant failure. With a new surgical technique facilitating an anterolateral approach to the hip joint the blood supply is left intact as well as the muscle tendons.
HYPOTHESIS:
An anterolateral surgical approach in resurfacing hip arthroplasty will 1) preserve the blood supply to the femoral head and neck and improve implant longevity, and 2) spare the muscle tendons and ease patient recovery.
METHOD and FACILITIES:
50 patients, aged 30 to 60 years, with osteoarthrosis of the hip will be randomised to a RHA inserted by either an anterolateral or a posterolateral surgical approach. Primary points of evaluation are 1) blood supply to the femoral head and neck measured intraoperatively by Laser Doppler flowmetry and postoperatively by microdialysis established during surgery. Secondary points of evaluation are 1) implant fixation measured by radiostereometric analysis (RSA), and 2) periprosthetic bone mineral density (BMD) measured by dual energy x-ray absorptiometry (DEXA), 3) gait analysis and 4) clinical scores of function, pain and activities of daily living (Harris Hip Score , Visual Analogue Scale).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nina Dyrberg Lorenzen, MD
- Phone Number: + 45 8949 7885
- Email: nina.dyrberg.lorenzen@ki.au.dk
Study Contact Backup
- Name: Kjeld Søballe, Professor, Dr. Med, MD
- Phone Number: +45 8949 7425
- Email: kjeld@soballe.com
Study Locations
-
-
Aarhus County
-
Aarhus C, Aarhus County, Denmark, 8000
- Aarhus University Hospital, Department of Orthopaedic Surgery, Tage-Hansens Gade 2
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Primary hip OA;
- Secondary hip OA due to mild and moderate acetabular dysplasia;
- Sufficient bone quality for cementless acetabular component;
- Suited for resurfacing of the femoral head, pre and intraoperatively assessed;
- Age 30 to 60 years.
Exclusion Criteria:
- Neuromuscular or vascular diseases in affected leg;
- Patients found intra-operatively to be unsuited for a cementless acetabular component or cementing of the femoral component;
- Need of NSAID postoperatively;
- Fracture sequelae;
- Females at risk of pregnancy, no safe contraceptives;
- Severe hip dysplasia;
- Sequelae from hip disease in childhood;
- Medicine with large effect on bone density, K vitamin antagonists, loop-diuretics;
- Alcoholism, females over 14 units per week, males over 21 units per week; AVN;
- Osteoporosis.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Posterior approach
Posterior surgical approach in hip resurfacing arthroplasty
|
two different surgical approaches in hip resurfacing arthroplasty
Other Names:
|
Active Comparator: Anterolateral approach
Anterolateral surgical approach in hip resurfacing arthroplasty
|
two different surgical approaches in hip resurfacing arthroplasty
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
femoral head blood flow, evaluated by Laser Doppler Flowmetry
Time Frame: during surgery
|
during surgery
|
femoral head metabolism, evaluated by microdialysis
Time Frame: 3 days
|
3 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
implant fixation, evaluated by RSA (radiostereogrammetric analysis)
Time Frame: postoperatively; 3 months; 1,2 and 5 years
|
postoperatively; 3 months; 1,2 and 5 years
|
periprosthetic bone mineral density, evaluated by DEXA
Time Frame: pre- and postoperatively; 1 and 2 years
|
pre- and postoperatively; 1 and 2 years
|
gait function, evaluated by gait analysis
Time Frame: preoperatively; 3 months and 1 year
|
preoperatively; 3 months and 1 year
|
patient recovery, evaluated by Harris Hip Score and Visual Analogue Scale
Time Frame: preoperatively and 3 months
|
preoperatively and 3 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20070082
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteonecrosis
-
McGill University Health Centre/Research Institute...UnknownOsteonecrosis of Femoral Head | Osteonecrosis; Aseptic, IdiopathicCanada
-
Fundació d'investigació Sanitària de les Illes...RecruitingOsteonecrosis of the Jaw, Bisphosphonate Induced | Osteonecrosis of the Jaw, Bisphosphonate RelatedSpain
-
AmgenCompletedOsteonecrosis of the JawFrance, Germany, Italy, United States, Belgium, United Kingdom, Spain, Greece, Canada, Denmark, Finland
-
Centre Hospitalier Sud FrancilienTerminatedOsteonecrosis Due to Drugs, JawFrance
-
Shiraz University of Medical SciencesShahid Beheshti University of Medical SciencesCompletedOsteonecrosis Due to Drugs, Jaw
-
Red de Terapia CelularFundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia and other collaboratorsUnknown
-
Kaohsiung Medical University Chung-Ho Memorial...National Taiwan University Hospital; Merck Sharp & Dohme LLC; National Cheng-Kung...UnknownNon-Traumatic OsteonecrosisTaiwan
-
University of PalermoCompletedMEDICATION RELATED OSTEONECROSIS OF THE JAWItaly
-
University of PalermoSuspendedMEDICATION RELATED OSTEONECROSIS OF THE JAWItaly
-
Shengjing HospitalCompletedOsteonecrosis of Femoral Head
Clinical Trials on Surgical approach (ReCap Hip Resurfacing System)
-
Zimmer BiometCompletedArthritis | Avascular NecrosisBelgium
-
Zimmer BiometAarhus University HospitalCompletedArthritis | Avascular NecrosisDenmark
-
St. Anna Ziekenhuis, Geldrop, NetherlandsCompletedArthritis | Avascular NecrosisNetherlands
-
Zimmer BiometBiomet U.K. Ltd.Terminated
-
Zimmer BiometBiomet U.K. Ltd.WithdrawnOsteoarthritis of the Hip
-
OrthoCarolina Research Institute, Inc.Completed
-
Ottawa Hospital Research InstituteCorinCompleted
-
Zimmer BiometCompleted
-
CorinCompletedOsteoarthritis | Rheumatoid Arthritis | Avascular NecrosisUnited States
-
Biomet Orthopedics, LLCWithdrawnArthritis | Osteoarthritis | Rheumatoid Arthritis | Traumatic Arthritis